FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161888051> ?p ?o ?g. }

• W2161888051 endingPage "5138" @default.
• W2161888051 startingPage "5124" @default.
• W2161888051 abstract "Evidence from C57BL/6 mice suggests that CD8(+) T cells, specific to the immunodominant HSV-1 glycoprotein B (gB) H-2(b)-restricted epitope (gB498-505), protect against ocular herpes infection and disease. However, the possible role of CD8(+) T cells, specific to HLA-restricted gB epitopes, in protective immunity seen in HSV-1-seropositive asymptomatic (ASYMP) healthy individuals (who have never had clinical herpes) remains to be determined. In this study, we used multiple prediction algorithms to identify 10 potential HLA-A*02:01-restricted CD8(+) T cell epitopes from the HSV-1 gB amino acid sequence. Six of these epitopes exhibited high-affinity binding to HLA-A*02:01 molecules. In 10 sequentially studied HLA-A*02:01-positive, HSV-1-seropositive ASYMP individuals, the most frequent, robust, and polyfunctional CD8(+) T cell responses, as assessed by a combination of tetramer, IFN-γ-ELISPOT, CFSE proliferation, CD107a/b cytotoxic degranulation, and multiplex cytokine assays, were directed mainly against epitopes gB342-350 and gB561-569. In contrast, in 10 HLA-A*02:01-positive, HSV-1-seropositive symptomatic (SYMP) individuals (with a history of numerous episodes of recurrent clinical herpes disease) frequent, but less robust, CD8(+) T cell responses were directed mainly against nonoverlapping epitopes (gB183-191 and gB441-449). ASYMP individuals had a significantly higher proportion of HSV-gB-specific CD8(+) T cells expressing CD107a/b degranulation marker and producing effector cytokines IL-2, IFN-γ, and TNF-α than did SYMP individuals. Moreover, immunization of a novel herpes-susceptible HLA-A*02:01 transgenic mouse model with ASYMP epitopes, but not with SYMP epitopes, induced strong CD8(+) T cell-dependent protective immunity against ocular herpes infection and disease. These findings should guide the development of a safe and effective T cell-based herpes vaccine." @default.
• W2161888051 created "2016-06-24" @default.
• W2161888051 creator A5003474726 @default.
• W2161888051 creator A5010907671 @default.
• W2161888051 creator A5010966529 @default.
• W2161888051 creator A5012729908 @default.
• W2161888051 creator A5015237203 @default.
• W2161888051 creator A5029278512 @default.
• W2161888051 creator A5037285448 @default.
• W2161888051 creator A5038180990 @default.
• W2161888051 creator A5044191289 @default.
• W2161888051 creator A5052763696 @default.
• W2161888051 creator A5053120770 @default.
• W2161888051 creator A5054482428 @default.
• W2161888051 creator A5062310236 @default.
• W2161888051 creator A5072664803 @default.
• W2161888051 creator A5086263808 @default.
• W2161888051 creator A5088801199 @default.
• W2161888051 creator A5091594147 @default.
• W2161888051 date "2013-11-15" @default.
• W2161888051 modified "2023-10-06" @default.
• W2161888051 title "Asymptomatic HLA-A*02:01–Restricted Epitopes from Herpes Simplex Virus Glycoprotein B Preferentially Recall Polyfunctional CD8+ T Cells from Seropositive Asymptomatic Individuals and Protect HLA Transgenic Mice against Ocular Herpes" @default.
• W2161888051 cites W1520019726 @default.
• W2161888051 cites W1549560588 @default.
• W2161888051 cites W1597232350 @default.
• W2161888051 cites W1605851537 @default.
• W2161888051 cites W1640810623 @default.
• W2161888051 cites W1748491164 @default.
• W2161888051 cites W1756803618 @default.
• W2161888051 cites W1826514729 @default.
• W2161888051 cites W1907564416 @default.
• W2161888051 cites W1967684158 @default.
• W2161888051 cites W1973571641 @default.
• W2161888051 cites W1979280812 @default.
• W2161888051 cites W1985632536 @default.
• W2161888051 cites W1987088416 @default.
• W2161888051 cites W1990294597 @default.
• W2161888051 cites W1997508510 @default.
• W2161888051 cites W2001087856 @default.
• W2161888051 cites W2010756468 @default.
• W2161888051 cites W2014793625 @default.
• W2161888051 cites W2019840235 @default.
• W2161888051 cites W2020923013 @default.
• W2161888051 cites W2029942344 @default.
• W2161888051 cites W2034847884 @default.
• W2161888051 cites W2042361781 @default.
• W2161888051 cites W2045010575 @default.
• W2161888051 cites W2046229795 @default.
• W2161888051 cites W2059984497 @default.
• W2161888051 cites W2064018751 @default.
• W2161888051 cites W2067409964 @default.
• W2161888051 cites W2074254659 @default.
• W2161888051 cites W2076993187 @default.
• W2161888051 cites W2077025077 @default.
• W2161888051 cites W2083208889 @default.
• W2161888051 cites W2085550499 @default.
• W2161888051 cites W2086769942 @default.
• W2161888051 cites W2089852414 @default.
• W2161888051 cites W2095899901 @default.
• W2161888051 cites W2096406142 @default.
• W2161888051 cites W2103323325 @default.
• W2161888051 cites W2103738194 @default.
• W2161888051 cites W2107533711 @default.
• W2161888051 cites W2108791678 @default.
• W2161888051 cites W2115390885 @default.
• W2161888051 cites W2119216636 @default.
• W2161888051 cites W2123114762 @default.
• W2161888051 cites W2124642065 @default.
• W2161888051 cites W2125248795 @default.
• W2161888051 cites W2137108105 @default.
• W2161888051 cites W2139182877 @default.
• W2161888051 cites W2143106728 @default.
• W2161888051 cites W2153485954 @default.
• W2161888051 cites W2156555210 @default.
• W2161888051 cites W2159454255 @default.
• W2161888051 cites W2160893466 @default.
• W2161888051 cites W2166213347 @default.
• W2161888051 cites W2170338229 @default.
• W2161888051 cites W2170541012 @default.
• W2161888051 cites W2310632873 @default.
• W2161888051 cites W2319146475 @default.
• W2161888051 doi "https://doi.org/10.4049/jimmunol.1301415" @default.
• W2161888051 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4057607" @default.
• W2161888051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24101547" @default.
• W2161888051 hasPublicationYear "2013" @default.
• W2161888051 type Work @default.
• W2161888051 sameAs 2161888051 @default.
• W2161888051 citedByCount "47" @default.
• W2161888051 countsByYear W21618880512014 @default.
• W2161888051 countsByYear W21618880512015 @default.
• W2161888051 countsByYear W21618880512016 @default.
• W2161888051 countsByYear W21618880512017 @default.
• W2161888051 countsByYear W21618880512018 @default.
• W2161888051 countsByYear W21618880512019 @default.
• W2161888051 countsByYear W21618880512020 @default.
• W2161888051 countsByYear W21618880512021 @default.
• W2161888051 countsByYear W21618880512022 @default.
• W2161888051 countsByYear W21618880512023 @default.

• next